Real-Time AI-Driven Decision Support Aids Catheter Ablation
By Lori Solomon HealthDay Reporter
WEDNESDAY, May 7, 2025 -- An artificial intelligence (AI)-driven model can significantly improve procedural safety in cardiac electrophysiology with real-time decision support, according to a study presented at the annual meeting of the Heart Rhythm Society, held from April 24 to 27 in San Diego.
Chih-Min Liu, M.D., Ph.D., from Taipei Veterans General Hospital in Taiwan, and colleagues developed the DeePRISM model using retrospective data from 110 patients with persistent atrial fibrillation (AF), incorporating deep learning and PRISM (Morphological Repetitiveness by Periodicity and Similarity) analysis to analyze intracardiac electrograms and predict AF termination sites during catheter ablation. An additional 37 patients with persistent AF were used to prospectively validate the model.
The researchers found that the DeePRISM model achieved strong performance in the independent test set with an area under the curve of 0.87 (sensitivity, 74.3 percent, specificity, 95.4 percent, overall accuracy, 95.4 percent). Roughly four in 10 patients (40.5 percent) achieved acute AF termination when undergoing DeePRISM-guided ablation. During a mean follow-up of 27.3 months, the DeePRISM group had significantly superior arrhythmia-free survival versus controls (70.3 versus 35.1 percent). Additionally, DeePRISM-guided ablation significantly reduced the risk for AF recurrence (hazard ratio, 0.10) without any periprocedural complications.
"With the introduction of the DeePRISM model, we are taking a significant step forward in the treatment of persistent atrial fibrillation," Liu said in a statement. "Our study shows that AI-driven, real-time analysis not only enhances the success of the procedure but also ensures patient safety, marking a promising advance in electrophysiology."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
Marine Microplastic Levels Linked to Cardiometabolic Disease Prevalence
WEDNESDAY, June 18, 2025 -- In coastal counties, marine microplastic levels (MMLs) are associated with the prevalence of cardiometabolic diseases, according to a study published...
Researchers Quantify Magnitude of Cardiovascular Risk Associated With Cannabis
WEDNESDAY, June 18, 2025 -- Cannabis use is associated with major adverse cardiovascular events (MACE), according to a systematic review based on real-world data published online...
Survival Up for CABG With Surgical Ablation in Atrial Fibrillation
FRIDAY, June 13, 2025 -- Medicare beneficiaries with preexisting atrial fibrillation undergoing coronary artery bypass grafting (CABG) who undergo concomitant surgical ablation...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.